Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 1881-1886

  Oikawa, Tsutomu ^a   Sasaki, Miyuki ^a   Inose, Masayo ^a   Shimamura, Mariko ^a   Kuboki, Hiroshi ^b   Hirano, Shin Ichi ^b   Kumagai, Hiroyuki ^b   Ishizuka, Masaaki ^c   Takeuchi, Tomio ^c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b MERCIAN CORPORATION   (Japan)

^c Microbial Chemistry Research Foundation   (Japan)

Author keywords

Cytogenin; Embryonic angiogenesis; In vivo; Oral angiogenesis inhibitor; Tumor angiogenesis

Indexed keywords

8 HYDROXY 3 HYDROXYMETHYL 6 METHOXYISOCOUMARIN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; COUMARIN DERIVATIVE; CYTOGENIN; PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

AIR SAC; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL CULTURE; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; HUMAN; HUMAN CELL; INTRAGASTRIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOLOGY; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ALLANTOIS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CHORION; COUMARINS; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED ICR; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SARCOMA 180; UMBILICAL VEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030860861     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Folkman J: Clinical applications of research on angiogenesis. New Engl J Med 333: 1757-1763, 1995.
2. Herblin WF, Brem S, Fan T-P and Gross JL: Recent advances in angiogenesis inhibitors. Exp Opin The: Patents 4: 641-654, 1994.
3. Oikawa T: Strategies to find novel angiogenesis inhibitors as potential therapeutic agents for cancer. Curr Med Chem 1: 406-417, 1995.
4. Kumagai H, Masuda T, Ohsono M, Hattori S, Naganawa H, Sawa T, Hamada M, Ishizuka M and Takeuchi T: Cytogenin, a novel antitumor substance. J Antibiot 43: 1505-1507, 1990.
5. Kumagai H, Masuda T, Ishizuka M and Takeuchi T: Antitumor activity of cytogenin. J Antibiot 48: 175-178, 1995.
6. Hirano S, Wakazono K, Agata N, Mase T, Yamamoto R, Matsufuji M, Sakata N, Iguchi H, Tone H, Ishizuka M, Takeuchi T and Abe C: Effects of cytogenin, a novel anti-arthritic agent, on type II collagen- induced arthritis in DBA/1J mice and adjuvant arthritis in Lewis rats. Int J Tiss Reac 16: 155-162, 1994.
7. Kumagai H, Masuda T, Sakashita M, Ishizuka M and Takeuchi T: Modulation of macrophage activity in tumor bearing mice by cytogenin. J Antibiot 48: 321-325, 1995.
8. Kumagai H, Osono M, Iijima M, Sakashita M, Ishizuka M and Takeuchi T: Action of cytogenin on lymphoid cells and their cytokine production. J Antibiot 48: 317-320, 1995.
9. Oikawa T, Hasegawa M, Shimamura M, Ashino H, Murota S and Morita I: Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor. Biochem Biophys Res Commun 181: 1070- 1076, 1991.
10. Oikawa T, Hirotani K, Nakamura O, Shudo K, Hiragun A and Iwaguchi T: A highly potent antiangiogenic activity of retinoids. Cancer Lett 48: 157-162, 1989.
11. 3 analogues. Eur J Pharmacol 178: 247-250, 1990.
12. Tanaka NG, Sakamoto N, Inoue K, Korenaga H, Kadoya S, Ogawa H and Osady Y: Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid. Cancer Res 49: 6727-6730, 1989.
13. Sidky YA and Borden EC: Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47: 5155-5161, 1987.
14. Plunkett ML and Hailey JA: An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab Invest 62: 510- 517, 1990.
15. Downs E.C, Robertson NE, Riss TL and Plunkett ML: Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol 152: 422-429, 1992.
16. Costa M, Danesi R, Agen C, Di Paolo A, Basolo F, Del Bianchi S and Del Tacca O: MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery. Cancer Res 54: 9-11, 1994.
17. Majewski S, Szmurlo A, Marczak M, Jablonska S and Bollag W: Synergistic effect of retinoids and Interferon a on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Int J Cancer 57: 81-85, 1994.
18. Oikawa T, Ito H, Ashino H, Toi M, Tominaga T, Morita I and Murota S: Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis. Eur J Pharmacol 241: 221-227, 1993.
19. Ashino-Fuse H, Takano Y, Oikawa T, Shimamura M and Iwaguchi T: Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells. Int J Cancer 44: 859-864, 1989.
20. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H and Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557, 1990.
21. Peacock DJ, Banquerigo ML and Brahn E: Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 175: 1135-1138, 1992.
22. Cozzolino F, Torcia M, Aldinucci D, Ziche M, Almerigogna F, Bani D and Stern DM: Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 87: 6487-6491, 1990.
23. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH and Tosato G: Human interferon- inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182: 155-162, 1995.
24. Stricter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan, S-Y, Roczniak S and Shanafelt AB: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348- 27357, 1995.
25. Voest E E, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ and Folkman J: Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87: 581-586, 1995.
26. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA and Koch AE: Production of angiogenic activity by human monocytes requires an L- arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91: 4190-4194, 1994.
27. Ziehe M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P and Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin invest 94: 2036-2044, 1994.
28. Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B and Isaacs JT: Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res 53: 1833-1837, 1993.
29. Kohn EC, Alessandro R, Spoonster J, Wersto RP and Liotta LA: Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 92: 1307-1311, 1995.